FormFactor Stock News

Thanks to the just-released results, we follow up on our comps analysis on the half-year companies' performance. We list five additional upsides to Technoprobe.

LIVERMORE, Calif., Sept. 26, 2022 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) today announced the appointment of Brian White to its Board of Directors effective immediately.

FormFactor surprised the Street with weak guidance for Q3'22, as management sees lower demand from foundry and logic customers. See why FORM stock is a Buy now.

FormFactor surprised the Street with weak guidance for Q3'22, as management is seeing lower demand from foundry and logic customers, particularly in compute and mobile. Volatility is nothing new for t

LIVERMORE, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the following investor conferences:

LIVERMORE, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) is pleased to announce its participation in the following investor conferences:

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Getty Images Holdings, Inc. (NYSE: GETY) shares jumped 106.7% to $21.69 after nearly 99.4% of shares were redeemed by CCNB shareholders. AMTD Digital Inc. (NYSE: HKD) gained 27.8% to $230.00 on conti

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11, 20

FormFactor's (FORM) second-quarter 2022 results are driven by strong demand for Foundry & Logic, Flash and Systems.

Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) gained 231% to $2.63 on news that the company will be acquired By Henry Crown and Company for $3.25 per share. Petros Pharmaceuticals, however, con

Bausch Health Companies Inc. (NYSE: BHC) shares fell 50.3% to $4.3166 following reports of an order on a patent litigation over Xifaxan. Pathward Financial, Inc. (NASDAQ: CASH) fell 25.2% to $32.26

FormFactor's (FORM) second-quarter 2022 results are driven by strong demand for Foundry & Logic, Flash and Systems.

FormFactor, Inc. (NASDAQ:FORM ) Q2 2022 Earnings Conference Call July 27, 2022 4:25 PM ET Company Participants Stan Finkelstein - Head of Investor Relations Michael Slessor - President & Chief Executi